AI Terminal
Achiko AG
Capital/Financing Update • Nov 30, 2020
804_rns_2020-11-30_d5ef268a-d9b5-4aa7-8853-609f516d27c2.html
Capital/Financing Update
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 30 November 2020 06:29
Achiko AG enters into a convertible note of up to CHF 2m with Negma Group
Achiko AG / Key word(s): Financing
30-Nov-2020 / 06:29 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.
Achiko AG enters into a convertible note of up to CHF 2m with Negma Group
Zurich, 30 November 2020 – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“the Company”) has entered into a new subordinated convertible loan transaction of up to CHF 2 million with Negma Group containing a conversion right into registered shares of the Company with a conversion period of 3 years.
The convertible loan transaction will close between January 1 and February 15, 2021 and comes attached with an issuance of 1,500,000 warrants in Negma Group’s favour. Each warrant confers the right to purchase one registered share of the Company, has an exercise period between the 30 th and 365 th day after the date of issuance of the warrants, and with an exercise price of CHF 0.35 (subject to customary adjustments).
This replaces the existing financing facility with Negma Group and is complementary to the Company’s recent announcements regarding updates to the capital increase of CHF 2.9m in October and the recent announcement of the convertible note with Yorkville of USD 2.5m.
“2020 has been critical for us in establishing solid foundations for Teman Sehat and Gumnuts”, said Steven Goh, CEO Achiko AG. “We’re grateful to everyone for their support and the recent transactions establishes the Company for an exciting 2021.”
About Achiko AG
We create solutions with a great user experience, for the transformation of the healthcare industry.
The development of our patent pending diagnostic testing kit for Covid-19 (Gumnuts) provides an easy and effective way to help people get the information they need. This is complemented by our mobile check-in app (Teman Sehat), enabling users to manage their diagnostic experiences on their own terms, safeguard their privacy, share experiences and find community.
We are headquartered in Zurich, with offices in Hong Kong, Jakarta, Singapore and Seoul.
Media contacts:
ACHIKO AG
Investor Relations
Switzerland
Marcus Balogh
Farner Consulting Ltd.
T: +41 44 266 67 67
Germany and Austria
Axel Mühlhaus / Dr Sönke Knop
edicto GmbH
T: +49 69 90 55 05-51
*Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.*
End of ad hoc announcement
| Language: | English |
| Company: | Achiko AG |
| Lavaterstrasse 66 | |
| 8002 Zurich | |
| Switzerland | |
| E-mail: | [email protected] |
| Internet: | https://www.achiko.com/ |
| ISIN: | CH0522213468 |
| Valor: | 48788430 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1151340 |
| End of Announcement | EQS Group News Service |